Convergence Investment Partners LLC Acquires Shares of 27,450 COPT Defense Properties (NYSE:CDP)

Convergence Investment Partners LLC bought a new stake in COPT Defense Properties (NYSE:CDP) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 27,450 shares of the company’s stock, valued at approximately $850,000.

Several other large investors have also recently bought and sold shares of the business. Blue Trust Inc. increased its holdings in shares of COPT Defense Properties by 53.8% in the 3rd quarter. Blue Trust Inc. now owns 14,021 shares of the company’s stock valued at $425,000 after acquiring an additional 4,904 shares during the last quarter. Raymond James & Associates increased its stake in COPT Defense Properties by 4.3% in the third quarter. Raymond James & Associates now owns 209,766 shares of the company’s stock valued at $6,362,000 after purchasing an additional 8,611 shares during the last quarter. Spirit of America Management Corp NY increased its stake in COPT Defense Properties by 100.0% in the third quarter. Spirit of America Management Corp NY now owns 4,000 shares of the company’s stock valued at $121,000 after purchasing an additional 2,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in COPT Defense Properties by 34.9% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,372 shares of the company’s stock valued at $134,000 after purchasing an additional 1,130 shares during the last quarter. Finally, Arkadios Wealth Advisors purchased a new position in shares of COPT Defense Properties in the 3rd quarter valued at $236,000.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CDP shares. Jefferies Financial Group dropped their target price on shares of COPT Defense Properties from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Thursday, January 2nd. Evercore ISI upped their target price on COPT Defense Properties from $33.00 to $36.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Truist Financial lifted their price target on COPT Defense Properties from $31.00 to $33.00 and gave the stock a “hold” rating in a research report on Wednesday, December 4th. Finally, BTIG Research increased their price objective on COPT Defense Properties from $33.00 to $38.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.88.

COPT Defense Properties Stock Performance

NYSE CDP opened at $26.87 on Thursday. The business’s 50-day moving average price is $29.89 and its 200 day moving average price is $30.47. COPT Defense Properties has a 52-week low of $22.20 and a 52-week high of $34.22. The firm has a market cap of $3.03 billion, a P/E ratio of 21.84 and a beta of 0.98. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 1.56.

COPT Defense Properties (NYSE:CDP) last announced its earnings results on Thursday, February 6th. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.33. COPT Defense Properties had a return on equity of 9.07% and a net margin of 18.44%. On average, equities research analysts expect that COPT Defense Properties will post 2.67 earnings per share for the current year.

COPT Defense Properties Company Profile

COPT Defense Properties is a real estate investment trust. It acquires, develops, manages, sells, and leases out office properties and data centers. The firm operates through the following segments: Defense/Information Technology Locations, Regional Office, Wholesale Data Center, and Other. The company was founded on January 22,1988 and is headquartered in Columbia, MD.